HTAC recommends COVID-19 Vaccine AstraZeneca under emergency use for reducing COVID-19 risk in persons aged 18 and older HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older HTA Philippines publishes HTAC Evaluation Framework for COVID-19 Vaccines HTAC recommends pooled RT-PCR testing to monitor COVID transmission in populations with low case numbers HTAC recommends Rapid Antigen Test kits for symptomatic COVID-19, contact tracing, managing outbreaks and supplementing lack of RT-PCR confirmatory testing HTAC releases guidance for ECMO, notes insufficient evidence to recommend use
HTAC recommends COVID-19 Vaccine AstraZeneca under emergency use for reducing COVID-19 risk in persons aged 18 and older
HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older
HTAC recommends pooled RT-PCR testing to monitor COVID transmission in populations with low case numbers
HTAC recommends Rapid Antigen Test kits for symptomatic COVID-19, contact tracing, managing outbreaks and supplementing lack of RT-PCR confirmatory testing
